Immunotherapy effective against neuroblastoma in children

A phase III study has shown that adding an antibody-based therapy that harnesses the body's immune system resulted in a 20 percent increase in the number of children living disease-free for at least two years with neuroblastoma. Neuroblastoma, a hard-to-treat cancer arising from nervous system cells, is responsible for 15 percent of cancer-related deaths in children. The researchers reported their findings - the first to show that immunotherapy could be effective against childhood cancer - online 14 May 2009 on the American Society of Clinical Oncology website in advance of presentation 2 June...

Read the whole article on

More from